Mephedrone
Mephedrone is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
162 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Urinary bladder neoplasms | D001749 | — | C67 | 5 | 9 | 3 | 1 | 1 | 17 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 7 | 8 | 2 | 1 | 1 | 14 |
| Colorectal neoplasms | D015179 | — | — | 6 | 5 | 2 | 1 | 1 | 12 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | 3 | 2 | 1 | 2 | 9 |
| Non-muscle invasive bladder neoplasms | D000093284 | — | — | 1 | 1 | 4 | 1 | 2 | 9 |
| Glaucoma | D005901 | EFO_0000516 | H40 | 1 | 1 | 1 | 1 | 4 | 7 |
| Open-angle glaucoma | D005902 | EFO_0004190 | H40.1 | — | — | — | 1 | 3 | 4 |
| Oropharyngeal neoplasms | D009959 | — | — | 1 | 1 | 1 | 1 | — | 3 |
| Second primary neoplasms | D016609 | — | — | — | — | 1 | 1 | — | 2 |
| Cervical intraepithelial neoplasia | — | — | D06 | — | — | — | 1 | — | 1 |
Show 3 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Carcinoma | D002277 | — | C80.0 | 5 | 10 | 7 | — | 3 | 22 |
| Anus neoplasms | D001005 | EFO_0003835 | C21 | 4 | 8 | 1 | — | 1 | 12 |
| Neoplasms | D009369 | — | C80 | 4 | 4 | 4 | — | 1 | 11 |
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | 3 | 3 | 3 | — | — | 9 |
| Squamous cell carcinoma | D002294 | — | — | 4 | 7 | 1 | — | — | 8 |
| Prostatic neoplasms | D011471 | — | C61 | 1 | 6 | 1 | — | — | 7 |
| Lymphoma | D008223 | — | C85.9 | 2 | 5 | 2 | — | — | 7 |
| Transitional cell carcinoma | D002295 | — | — | 2 | — | 3 | — | 2 | 7 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | 1 | 2 | 2 | — | 2 | 7 |
| Castration-resistant prostatic neoplasms | D064129 | — | — | 1 | 4 | 1 | — | — | 5 |
Show 28 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 2 | 5 | — | — | — | 6 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 3 | 1 | — | — | — | 4 |
| Lung neoplasms | D008175 | — | C34.90 | 2 | 3 | — | — | — | 4 |
| B-cell lymphoma | D016393 | — | — | 2 | 3 | — | — | — | 4 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 3 | — | — | — | 3 |
| Multiple myeloma | D009101 | — | C90.0 | — | 3 | — | — | — | 3 |
| Glioma | D005910 | EFO_0000520 | — | — | 3 | — | — | — | 3 |
| Ovarian epithelial carcinoma | D000077216 | — | — | 2 | 1 | — | — | — | 3 |
| Endometrial neoplasms | D016889 | EFO_0004230 | — | 1 | 1 | — | — | — | 2 |
| Head and neck neoplasms | D006258 | — | — | — | 1 | — | — | 1 | 2 |
Show 55 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pterygium | D011625 | — | H11.0 | 1 | — | — | — | 2 | 3 |
| Appendiceal neoplasms | D001063 | EFO_0003880 | C18.1 | 2 | — | — | — | — | 2 |
| Endometrioid carcinoma | D018269 | — | — | 2 | — | — | — | — | 2 |
| Acinar cell carcinoma | D018267 | — | — | 2 | — | — | — | — | 2 |
| Amphetamine-related disorders | D019969 | EFO_0004701 | F15 | 2 | — | — | — | — | 2 |
| Autonomic nervous system diseases | D001342 | EFO_0009532 | G90 | 1 | — | — | — | — | 1 |
| Adult t-cell leukemia-lymphoma | D015459 | — | C91.5 | 1 | — | — | — | — | 1 |
| Deltaretrovirus infections | D006800 | EFO_1001303 | — | 1 | — | — | — | — | 1 |
| Htlv-i infections | D015490 | EFO_0007316 | — | 1 | — | — | — | — | 1 |
| Mucinous cystadenocarcinoma | D018282 | — | — | 1 | — | — | — | — | 1 |
Show 14 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Heart failure | D006333 | EFO_0003144 | I50 | — | — | — | — | 2 | 2 |
| Esophageal stenosis | D004940 | — | K22.2 | — | — | — | — | 2 | 2 |
| Pathologic constriction | D003251 | — | — | — | — | — | — | 2 | 2 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | — | — | — | 1 | 1 |
| Muscle weakness | D018908 | — | — | — | — | — | — | 1 | 1 |
| Deglutition disorders | D003680 | — | R13.1 | — | — | — | — | 1 | 1 |
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | — | — | — | 1 | 1 |
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | — | — | — | 1 | 1 |
| Gastroparesis | D018589 | EFO_1000948 | K31.84 | — | — | — | — | 1 | 1 |
| Traumatic brain injuries | D000070642 | — | S06 | — | — | — | — | 1 | 1 |
Show 28 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Mephedrone |
| INN | _ |
| Description | Mephedrone, also known as 4-methylmethcathinone, 4-MMC, and 4-methylephedrone, is a synthetic stimulant drug of the amphetamine and cathinone classes. Slang names include drone, M-CAT, White Magic, meow meow and bubble. It is chemically similar to the cathinone compounds found in the Khat plant of eastern Africa. It comes in the form of tablets or crystals, which users can swallow, snort or inject, producing effects similar to those of MDMA, amphetamines and cocaine.
|
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CNC(C)C(=O)c1ccc(C)cc1 |
Identifiers
| PDB | — |
| CAS-ID | 1189805-46-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL4094396 |
| ChEBI ID | — |
| PubChem CID | 29982893 |
| DrugBank | — |
| UNII ID | G0XL35SUXP (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
65 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use